GeneralConnection.com ➔ Dictionary
Dictionary Search

metastatic

Synonyms

Adjective

1. pathologic process

2. pathological process

Usage
FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance - Yahoo Finance
Metastatic male breast cancer: Joe’s story - Roswell Park Comprehensive Cancer Center
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer - AJMC
Apalutamide-Induced Pneumonitis Presenting as Severe Hypoxemic Respiratory Failure in Metastatic Prostate Cancer: A Case Report - Cureus
PSA Response as a Guide to Patient-Centered Treatment Decisions in Metastatic Hormone-Sensitive Prostate Cancer - Tanya Dorff - UroToday
Study uncovers mechanism driving metastasis in aggressive gastric cancer - News-Medical
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy - BioSpace
Scientists Uncover a Hidden Switch That Helps Colon Cancer Spread to the Liver - SciTechDaily
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer - Yahoo Finance
Daraxonrasib Extends Median Survival in Previously Treated Pancreatic Cancer - The ASCO Post
Dato-DXd Earns CHMP Positive Opinion for First-Line Metastatic TNBC - OncLive
FDA Approves Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer Treatment - Breast Cancer Research Foundation | BCRF
FDA Approves Ibrance Combo for Maintenance Treatment of HR-Positive, HER2-Positive Metastatic Breast Cancer - Cure Today
Breast Cancer Palbociclib-Based Regimen Approved for HR-Positive, HER2-Positive Metastatic Disease - The ASCO Post
SystImmune Announces First Approval of Iza-bren for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma in China - PR Newswire
FDA Approves Palbociclib for HR+/HER2+ Metastatic Breast Cancer Maintenance - Oncology Nursing News
FDA Approves Palbociclib Combo in HR+, HER2+ Metastatic Breast Cancer - CancerNetwork
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy - Business Wire
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer - Pharmaceutical Executive
FDA Approves Palbociclib-Based Maintenance Regimen for HR-Positive, HER2-Positive Metastatic Breast Cancer - Pharmacy Times
A Randomized Phase III Study Evaluating Izalontamab Brengitecan (Iza-bren) Versus Physician’s Choice of Chemotherapy in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer (TNBC) - OncLive
Generic Enzalutamide Receives Tentative FDA Approval in Prostate Cancer - CancerNetwork
FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer | PharmExec - Pharmaceutical Executive
FDA Approves Afami-cel in Metastatic Synovial Sarcoma - CancerNetwork
Pemigatinib for unresectable advanced or metastatic cholangiocarcinoma with FGFR2 rearrangement: results from the confirmatory Phase 3 FIGHT-302 trial - OncLive
Ibrance Wins FDA Approval for HR-Positive, HER2-Positive Metastatic Breast Cancer Maintenance Therapy - Pharmaceutical Executive
ASCO 2026 Data Refinements and Deep Response Analysis in HER2-Positive Metastatic Breast Cancer - CancerNetwork
FDA Approves Palbociclib Plus Trastuzumab, With/Without Pertuzumab, and ET as Maintenance in HR+, HER2+ Metastatic Breast Cancer - OncLive
Colon cancer cells may change identity to metastasize - Cornell Chronicle
Sacituzumab Govitecan Receives FDA Approval Across 2 TNBC Indications - CancerNetwork
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer - Business Wire
FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance - Business Wire
Gilead’s Trodelvy approved by EC as first-line treatment for metastatic triple-negative breast cancer - PMLiVE
U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer - Business Wire
Katy Beckermann: A Preoperative Model for Cancer-Specific Mortality in Non-Metastatic RCC - Oncodaily
FDA Approves Palbociclib-Based Maintenance Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer - Oncodaily
Trop-2-Directed ADC Sacituzumab Govitecan Earns FDA Approval in First-Line Metastatic Triple-Negative Breast Cancer - BioPharm International
Zanzalintinib Plus Atezolizumab Misses OS End Point in Liver Metastasis–Free mCRC Subgroup - Targeted Oncology
as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 Inhibitors - Business Wire
European Commission Approves Trodelvy for First-Line Metastatic TNBC in Patients Ineligible for PD-(L)1 Inhibitors - Oncodaily
FDA Approves Afamitresgene Autoleucel for Patients With Unresectable or Metastatic Synovial Sarcoma - HMP Global Learning Network
Tigerlily Foundation Celebrates FDA Approval of Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer - PR Newswire
Zanzalintinib Plus Atezolizumab Misses OS End Point in Non–Liver Metastases Subgroup in Refractory mCRC - OncLive
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial - Nature
FDA Approves Antibody-Drug Conjugate for Triple-Negative Breast Cancer - The ASCO Post
Testosterone May Offer Anti-Tumor Activity in Glioblastoma - Cleveland Clinic
Outcomes With SC Amivantamab Plus Lazertinib in Frontline EGFR+ NSCLC - Targeted Oncology
Palbociclib Gains HER2+ Breast Cancer Maintenance Indication - Medscape
FDA Approves Sacituzumab Govitecan for Triple-Negative Breast Cancer - Oncology News Central
Joaquín Cabrera Rodríguez: PD-L1 Inhibitors Fail to Reduce Brain Metastasis Risk in ES-SCLC - Oncodaily
Metastatic Breast Cancer: Current and Emerging Treatments - Medscape Reference
Investigational daily pill doubles survival in metastatic pancreatic cancer, study shows - Newsroom | UCLA
Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026 - BioSpace
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics - Nature
Sacituzumab Govitecan Gains First-Line TNBC Indications - Medscape
Type I interferons induced upon respiratory viral infection impair lung metastatic initiation - PNAS
Oligometastatic prostate cancer — bridging the gap between localized and metastatic disease - Nature
Trial offers hope for metastatic pancreatic cancer - Mayo Clinic
Sacituzumab Govitecan Approved in Europe for First-Line PD-L1 Inhibitor–Ineligible TNBC - OncLive
Advanced age increases cancer-specific mortality in bone-only metastatic prostate cancer: a SEER analysis - Nature
A glucocorticoid–FAS axis controls immune evasion during metastatic seeding - Nature
TROP2 Drug Wins Two New Indications in Triple-Negative Breast Cancer - MedPage Today
A New Clinical Trial for Metastatic Breast Cancer Opens - UNC Health
GLP-1 Agonists Associated With Major Reduction in Metastatic Cancer Progression - Targeted Oncology
FDA Approves Trodelvy Alone or With Keytruda for First-Line Triple-Negative Breast Cancer - Cure Today
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial - Nature
A hormetic transcriptional program coregulates invasion, proliferation and dormancy to define metastatic potential - Nature
Gilead Wins EC Approval to Expand Trodelvy's Label in Metastatic TNBC - Zacks Investment Research
Prostate cancer cells converge to an inflammatory-like state upon metastatic dissemination - Nature
The Benefits of Intensifying Prostate Cancer Treatment: Highlights From ASCO and ASCO GU - Oncology News Central
The potential directing role of chemokines for specific metastatic sites in breast cancer - Nature
Q&A: How Chemoimmunotherapy Has Impacted Survival in Veterans With ES-SCLC, Brain Metastases - Physician's Weekly
Ameloblastic Carcinoma: A Case Report with Emphasis on Relevant Diagnostic Aspects - Cureus
FDA Approves Sacituzumab Govitecan for First-Line TNBC Treatment - Targeted Oncology
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance - AJMC
Zanzalintinib/Atezolizumab Misses Survival End Point in Non-MSI-H mCRC Subgroup - CancerNetwork
Key ESR1 Data from ASCO 2026: Implications for Breast Cancer Care - Oncology News Central
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value - Science | AAAS
Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer - Harvard Medical School
Evolutionary characterization of lung cancer metastasis - Nature
Diagnostic Accuracy of Intraoperative Frozen Section Examination of Pelvic Lymph Nodes in Cervical Carcinoma: A Cross-Sectional Study in Eastern India - Cureus
Adjuvant Belzutifan in Combination With Pembrolizumab Receives FDA Approval in Renal Cell Carcinoma - The ASCO Post
Metastatic Breast Cancer Research: An Area of Focus for BCRF - Breast Cancer Research Foundation | BCRF
Elicio Therapeutics (ELTX) outlines ELI-002 7P combo trial plan in metastatic pancreatic cancer - Stock Titan
ULK1 promotes metastatic progression in experimental models of epithelial ovarian cancer | Oncogene - Nature
Your next steps if breast cancer becomes metastatic - Roswell Park Comprehensive Cancer Center
FDA Approves Gilead’s Trodelvy, Alone and With Merck’s Keytruda, in First-Line Metastatic TNBC - Oncodaily
Exelixis Provides Update on the Phase 3 STELLAR-303 Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Patients with Metastatic Colorectal Cancer - Business Wire
5 Takeaways from BCRF’s Webinar on Advancements in Metastatic Breast Cancer Care - Breast Cancer Research Foundation | BCRF
U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer - Eagle-Tribune
Metastatic Breast Cancer Retreat - Northside Hospital
Lactate mitochondrial oxidation drives stemness potential in metastatic breast cancer - Nature
Metastatic melanoma survivor trusts UT MD Anderson’s expertise and research - UT MD Anderson
UTSW, InterAct partner on novel gene therapy for metastatic cancer: Newsroom - UT Southwestern Medical Center
Inferring cancer type-specific patterns of metastatic spread using Metient - Nature
Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma - Nature
Yale Launches Innovative Clinical Trial for Metastatic Bladder Cancer - Yale School of Medicine
Editorial: Cancer metastases: mechanisms of tumor dissemination, formation of metastatic niche and anti-metastatic therapy - Frontiers
New platform aims to better predict metastatic cancer risk - News at IU
Amivantamab in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer - The ASCO Post
Foreign Language Equivalents
Foreign Language Equivalents of 'metastatic'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
mwtastatic,   metastayic,   metastaic,   meatstatic,   mmetastatic,   emtastatic,   metastatci,   metsstatic,   metasyatic,   metadtatic,   metastatoc,   metaatatic,   metastatuc,   meastatic,   metaststic,   mtastatic,   mrtastatic,   ,etastatic,   metastatc,   metastati,   etastatic,   metatsatic,   merastatic,   metaastatic,   metatatic,   metstatic,   metastaitc,   metastaticc,   metasttatic,   metastatix,   meetastatic,   metastattic,   metasstatic,   metasttic,   metastativ,   metsatatic,   metasatic,   netastatic,   metastaatic,   metasttaic,   metasattic,   metastaric,   metastatiic,   meyastatic,   mteastatic,   metasratic,   mettastatic
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z